The drug, called Atripla, combines the three most widely prescribed HIV drugs into one pill, providing patients with the simplest possible medication regimen.
In 1995, a combination drug treatment known as the “AIDS cocktail” was introduced. This type of therapy is now known as highly active antiretroviral therapy (HAART).
Reverse transcriptase: an enzyme required for HIV to duplicate itself. Triple «cocktail» therapy: use of a three-drug regimen to combat HIV infection. One of the three is usually a protease inhibitor.
Currently most people infected with HIV take a combination of three or more tablets per day to prevent the virus replicating and triggering Aids.
As with most drugs, HIV drug cocktails can give rise to unpleasant side effects. Among these potential side effect are: nausea, vomiting, diarrhea, weight loss, depression, dry mouth, fever, fatigue, rash, and peripheral neuropathy.
The Food and Drug Administration (FDA) announced approval of Atripla Tablets, a fixed-dose combination of three widely-used antiretroviral drugs, in a single tablet taken once a day, alone or in combination with other antiretroviral products for the treatment of HIV-1 infection in adults.